rs541051874
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033305.3(VPS13A):c.904C>T(p.Leu302Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,611,874 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 1 hom. )
Consequence
VPS13A
NM_033305.3 missense
NM_033305.3 missense
Scores
4
6
9
Clinical Significance
Conservation
PhyloP100: 2.12
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25796804).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS13A | NM_033305.3 | c.904C>T | p.Leu302Phe | missense_variant | 12/72 | ENST00000360280.8 | NP_150648.2 | |
VPS13A | NM_001018037.2 | c.904C>T | p.Leu302Phe | missense_variant | 12/71 | NP_001018047.1 | ||
VPS13A | NM_015186.4 | c.904C>T | p.Leu302Phe | missense_variant | 12/69 | NP_056001.1 | ||
VPS13A | NM_001018038.3 | c.904C>T | p.Leu302Phe | missense_variant | 12/69 | NP_001018048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13A | ENST00000360280.8 | c.904C>T | p.Leu302Phe | missense_variant | 12/72 | 1 | NM_033305.3 | ENSP00000353422.3 | ||
VPS13A | ENST00000376636.7 | c.904C>T | p.Leu302Phe | missense_variant | 12/71 | 1 | ENSP00000365823.3 | |||
VPS13A | ENST00000643348.1 | c.904C>T | p.Leu302Phe | missense_variant | 12/69 | ENSP00000493592.1 | ||||
VPS13A | ENST00000645632.1 | c.904C>T | p.Leu302Phe | missense_variant | 12/69 | ENSP00000496361.1 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151724Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151724
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249876Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135128
GnomAD3 exomes
AF:
AC:
3
AN:
249876
Hom.:
AF XY:
AC XY:
3
AN XY:
135128
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1460050Hom.: 1 Cov.: 31 AF XY: 0.0000317 AC XY: 23AN XY: 726278
GnomAD4 exome
AF:
AC:
31
AN:
1460050
Hom.:
Cov.:
31
AF XY:
AC XY:
23
AN XY:
726278
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151824Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74164
GnomAD4 genome
AF:
AC:
4
AN:
151824
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74164
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2024 | The c.904C>T (p.L302F) alteration is located in exon 12 (coding exon 12) of the VPS13A gene. This alteration results from a C to T substitution at nucleotide position 904, causing the leucine (L) at amino acid position 302 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Chorea-acanthocytosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Mar 05, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;.;T;.;.;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.;.;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;M;M;M;M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;.;.;.
REVEL
Benign
Sift
Benign
D;D;T;D;.;.;.
Sift4G
Pathogenic
D;D;D;D;.;.;.
Polyphen
D;D;D;D;D;D;D
Vest4
MutPred
Loss of catalytic residue at M299 (P = 0.0695);Loss of catalytic residue at M299 (P = 0.0695);Loss of catalytic residue at M299 (P = 0.0695);Loss of catalytic residue at M299 (P = 0.0695);Loss of catalytic residue at M299 (P = 0.0695);Loss of catalytic residue at M299 (P = 0.0695);Loss of catalytic residue at M299 (P = 0.0695);
MVP
MPC
0.57
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at